Literature DB >> 11338931

Polyethylenimines for in vivo gene delivery.

G F Lemkine1, B A Demeneix.   

Abstract

Branched and linear polyethylenimines (PEIs) are proving to be efficient, non-toxic and versatile agents for in vivo gene delivery by a number of routes. A major factor in the successful use of PEIs seems to be the small size of PEI/DNA complexes which can be achieved under controlled conditions of formulation, mainly by using PEIs of low molecular weights. This review considers the in vivo use of PEI, from formulation to delivery and analysis of gene expression. PEI delivery is already used for the analysis of numerous physiological processes. It is hoped that scrutiny of the mechanisms involved with PEI-based gene delivery at different levels of the transfection process and in different in vivo contexts will aid the transition towards its use in therapeutic situations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11338931

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN: 1464-8431


  23 in total

Review 1.  Improvement of DNA transfection with cationic liposomes.

Authors:  A Rocha; S Ruiz; J M Coll
Journal:  J Physiol Biochem       Date:  2002-03       Impact factor: 4.158

2.  Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene delivery.

Authors:  Rupa R Sawant; Shravan Kumar Sriraman; Gemma Navarro; Swati Biswas; Riddhi A Dalvi; Vladimir P Torchilin
Journal:  Biomaterials       Date:  2012-02-25       Impact factor: 12.479

Review 3.  DNA-based therapeutics and DNA delivery systems: a comprehensive review.

Authors:  Siddhesh D Patil; David G Rhodes; Diane J Burgess
Journal:  AAPS J       Date:  2005-04-08       Impact factor: 4.009

4.  Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies.

Authors:  V V Didenko; H Ngo; D S Baskin
Journal:  Anal Biochem       Date:  2005-09-15       Impact factor: 3.365

5.  Linear Polyethylenimine-DNA Nanoconstruct for Corneal Gene Delivery.

Authors:  Jason T Rodier; Ratnakar Tripathi; Michael K Fink; Ajay Sharma; Madhuri Korampally; Shubhra Gangopadhyay; Elizabeth A Giuliano; Prashant R Sinha; Rajiv R Mohan
Journal:  J Ocul Pharmacol Ther       Date:  2019 Jan/Feb       Impact factor: 2.671

6.  DNA nanoparticles with core-shell morphology.

Authors:  Preethi L Chandran; Emilios K Dimitriadis; Julianna Lisziewicz; Vlad Speransky; Ferenc Horkay
Journal:  Soft Matter       Date:  2014-08-19       Impact factor: 3.679

Review 7.  Nanomedicines for Malaria Chemotherapy: Encapsulation vs. Polymer Therapeutics.

Authors:  Sindisiwe Mvango; William M R Matshe; Abideen O Balogun; Lynne A Pilcher; Mohammed O Balogun
Journal:  Pharm Res       Date:  2018-10-15       Impact factor: 4.200

8.  DNA as therapeutics; an update.

Authors:  P Saraswat; R R Soni; A Bhandari; B P Nagori
Journal:  Indian J Pharm Sci       Date:  2009-09       Impact factor: 0.975

9.  A nanocomplex that is both tumor cell-selective and cancer gene-specific for anaplastic large cell lymphoma.

Authors:  Nianxi Zhao; Hitesh G Bagaria; Michael S Wong; Youli Zu
Journal:  J Nanobiotechnology       Date:  2011-01-31       Impact factor: 10.435

10.  Polyethylenimine-mediated gene delivery to the lung and therapeutic applications.

Authors:  Sante Di Gioia; Massimo Conese
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.